Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:41:06 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



News for U:RVNC from 2023-05-04 to 2024-05-03 - 23 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 16:05U:RVNCNews ReleaseRevance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
2024-04-12 08:00U:RVNCNews ReleaseRevance to Present New DAXXIFY(TM) Data at the American Academy of Neurology 2024 Annual Meeting
2024-03-27 16:05U:RVNCNews ReleaseRevance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-04 09:25U:RVNCNews ReleaseRevance Announces Pricing of $100.0 Million Public Offering of Common Stock
2024-03-04 06:37U:RVNCNews ReleaseRevance Announces Proposed Public Offering of Common Stock
2024-02-28 16:05U:RVNCNews ReleaseRevance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update
2024-02-21 08:01U:RVNCNews ReleaseRevance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
2024-02-21 08:00U:RVNCNews ReleaseRevance to Participate in Upcoming Investor Conferences
2024-02-02 08:00U:RVNCNews ReleaseRevance Receives Permanent J-Code for DAXXIFY ‚ ® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology ‚ ®
2024-02-01 08:00U:RVNCNews ReleaseRevance to Participate in the Guggenheim 6th Annual Biotechnology Conference
2024-01-08 08:00U:RVNCNews ReleaseRevance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
2023-11-08 16:06U:RVNCNews ReleaseRevance Reports Third Quarter 2023 Financial Results, Provides Corporate Update
2023-11-08 16:05U:RVNCNews ReleaseRevance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics
2023-11-06 08:00U:RVNCNews ReleaseRevance to Participate in Upcoming Investor Conferences
2023-11-01 08:00U:RVNCNews ReleaseRevance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
2023-10-26 08:00U:RVNCNews ReleaseDAXXIFY ‚ ® Becomes First Facial Injectable to be Named to TIME ¢ € ™s Best Inventions
2023-09-19 09:00U:RVNCNews ReleaseRevance Provides Corporate Update at Investor Day
2023-08-22 08:00U:RVNCNews ReleaseRevance to Host Investor Day on September 19, 2023
2023-08-14 08:00U:RVNCNews ReleaseU.S. FDA Approves First Therapeutic Indication for Revance ¢ € ™s DAXXIFY ‚ ® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
2023-08-08 16:05U:RVNCNews ReleaseRevance Reports Second Quarter 2023 Financial Results, Provides Corporate Update
2023-08-01 08:00U:RVNCNews ReleaseRevance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
2023-05-23 16:05U:RVNCNews ReleaseRevance to Participate in Upcoming Investor Conferences
2023-05-09 16:05U:RVNCNews ReleaseRevance Reports First Quarter 2023 Financial Results, Provides Corporate Update